RxDoctor Payments Data

Andrew Reichert, MD

Psychiatry · Amherst, NYNPI 1306849138

Payments from drug & device makers

$14,911in general payments, 2019–2025

Across 869 payments — averaging $17.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Otsuka America Pharmaceutical, Inc.$1K
  • Lundbeck LLC$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Johnson & Johnson$1K
  • Alkermes, Inc.$1K
  • plus $7K from 30 others

What the payments were for

  • Food & beverage$14,881100%
  • Education$300%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$14,911 in reported general payments places this provider in the 90th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$73,611
Medicare patients
188
Services billed
1,092

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine13$196,309
Austedo XrDeutetrabenazine26$170,126
TrintellixVortioxetine Hydrobromide117$82,314
AtivanLorazepam12$74,183
CaplytaLumateperone Tosylate26$47,013
AuvelityDextromethorphan Hbr/Bupropion43$43,707
RexultiBrexpiprazole16$34,734
VraylarCariprazine Hcl20$31,696
FetzimaLevomilnacipran Hcl36$20,199
ZoloftSertraline Hcl23$17,744
Buspirone Hcl692$11,755
Bupropion XlBupropion Hcl422$9,835
Vilazodone Hcl82$8,546
LamictalLamotrigine12$7,983
Aripiprazole290$7,803

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo, Austedo Xr$1,236$366,43639 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$849$82,314117 claims
AbbVieVraylar, Fetzima$1,542$51,89556 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$994$47,01326 claims
Axsome Therapeutics, Inc.Auvelity$413$43,70743 claims
Otsuka America Pharmaceutical, Inc.Rexulti$1,484$34,73416 claims
Almatica Pharma LLCSertraline Hcl$197$4,351325 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,713 psychiatry providers in New York.

Other psychiatry in Amherst

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →